In the United States, Wegovy (semaglutide) injection 2.4 mg is approved for adults and children aged 12 and older with obesity, or adults with overweight and a related medical condition, to help reduce excess body weight and maintain weight loss
doi: 10.1210/en.2012-1937 37
Some natural compound that keeps it from eating itself alive
Rand K, Qu W, Ho T, Clark S, Molloy P (2002) A Companion to Methods in Enzymology Methods 27 : 114120
Hepatology 67 , 12611269 (2018)
Some patients also notice an upset stomach, nausea, constipation, diarrhea, or a heavy, full feeling, especially at the beginning or with higher doses